Fluzoparib increases radiation sensitivity of non-small cell lung cancer (NSCLC) cells without BRCA1/2 mutation, a novel PARP1 inhibitor undergoing clinical trials
氟唑帕尼可提高不携带 BRCA1/2 突变的非小细胞肺癌 (NSCLC) 细胞的放射敏感性,是一种正在进行临床试验的新型 PARP1 抑制剂。
期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-019-03097-6
Luo, Jing; Dai, Xinchi; Hu, Hua; Chen, Jie; Zhao, Lujun; Yang, Changyong; Sun, Jifeng; Zhang, Lianmin; Wang, Qian; Xu, Shilei; Xu, Yue; Liu, Ningbo; Ying, Guoguang; Wang, Ping
肺癌
肿瘤
PARP1
肿瘤免疫
BRCA1
CLC
PARP
细胞生物学